O Shaughnessy Asset Management LLC acquired a new position in shares of Lantheus Holdings, Inc. (NASDAQ:LNTH) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 4,190 shares of the medical equipment provider’s stock, valued at approximately $116,000.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Great Point Partners LLC acquired a new position in Lantheus during the first quarter worth $13,880,000. Geode Capital Management LLC grew its stake in shares of Lantheus by 10.3% in the 1st quarter. Geode Capital Management LLC now owns 1,175,074 shares of the medical equipment provider’s stock worth $25,111,000 after acquiring an additional 110,116 shares in the last quarter. FORA Capital LLC grew its stake in shares of Lantheus by 30.2% in the 1st quarter. FORA Capital LLC now owns 4,487 shares of the medical equipment provider’s stock worth $96,000 after acquiring an additional 1,041 shares in the last quarter. Russell Investments Group Ltd. grew its position in Lantheus by 21.9% during the second quarter. Russell Investments Group Ltd. now owns 1,749,643 shares of the medical equipment provider’s stock valued at $48,357,000 after buying an additional 314,801 shares during the period. Finally, Barclays PLC grew its position in Lantheus by 12.9% during the first quarter. Barclays PLC now owns 83,713 shares of the medical equipment provider’s stock valued at $1,789,000 after buying an additional 9,547 shares during the period. Hedge funds and other institutional investors own 98.58% of the company’s stock.
Shares of NASDAQ LNTH opened at $25.97 on Wednesday. Lantheus Holdings, Inc. has a one year low of $10.52 and a one year high of $28.74. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.52 and a quick ratio of 2.09. The firm’s 50 day simple moving average is $25.83 and its two-hundred day simple moving average is $23.88. The stock has a market capitalization of $1.76 billion, a P/E ratio of -63.34, a PEG ratio of 2.59 and a beta of 1.45.
In other Lantheus news, CAO Andrea Sabens sold 1,242 shares of the stock in a transaction that occurred on Monday, August 16th. The shares were sold at an average price of $25.46, for a total transaction of $31,621.32. Following the transaction, the chief accounting officer now directly owns 67,312 shares in the company, valued at $1,713,763.52. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.40% of the stock is owned by company insiders.
Several research firms recently weighed in on LNTH. Zacks Investment Research lowered shares of Lantheus from a “buy” rating to a “hold” rating in a research report on Wednesday, August 4th. SVB Leerink reaffirmed a “buy” rating on shares of Lantheus in a research note on Sunday.
Lantheus Holdings, Inc engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes, and assist clinicians with the detection of cardiovascular disease. It operates through the U.S. and International geographical segments.
Further Reading: How is net asset value different from market price?
Receive News & Ratings for Lantheus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus and related companies with MarketBeat.com's FREE daily email newsletter.